Drug Shortage Report for LOVASTATIN

Last updated on 2017-07-19 History
Report ID 13322
Drug Identification Number 02220172
Brand name APO-LOVASTATIN - TAB 20MG
Common or Proper name LOVASTATIN
Company Name AA PHARMA INC
Market Status MARKETED
Active Ingredient(s) LOVASTATIN
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-06-19
Estimated end date 2017-07-20
Actual end date 2017-07-18
Shortage status Resolved
Updated date 2017-07-19
Company comments APO-LOVASTATIN 20 MG TAB 500 BTL available
Health Canada comments
Tier 3 Status No
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-06-19 English Compare
v2 2017-06-19 French Compare
v3 2017-06-19 French Compare
v4 2017-06-20 English Compare
v5 2017-07-19 English Compare
v6 2017-07-19 French Compare

Showing 1 to 6 of 6